BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/30/2021 9:35:11 AM | Browse: 548 | Download: 1589
 |
Received |
|
2021-07-28 10:12 |
 |
Peer-Review Started |
|
2021-07-28 10:13 |
 |
First Decision by Editorial Office Director |
|
2021-08-19 05:58 |
 |
Return for Revision |
|
2021-08-19 05:58 |
 |
Revised |
|
2021-08-24 13:39 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2021-10-12 08:02 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2021-10-14 02:30 |
 |
Articles in Press |
|
2021-10-14 02:30 |
 |
Edit the Manuscript by Language Editor |
|
2021-10-08 22:35 |
 |
Typeset the Manuscript |
|
2021-11-24 01:30 |
 |
Publish the Manuscript Online |
|
2021-11-30 09:35 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Respiratory System |
| Manuscript Type |
Retrospective Study |
| Article Title |
Teicoplanin combined with conventional vancomycin therapy for the treatment of pulmonary methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis infections
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Wei Wu, Min Liu, Jiajing Geng and Mei Wang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Mei Wang, MHSc, Attending Doctor, Laboratory Medicine, Bejing Tongren Hosptial, Capital Medical University, No. 2 West Ring South Road, Beijing 100176, China. wmeimeiw@163.com |
| Key Words |
Vancomycin; Teicoplanin; Methicillin-resistant Staphylococcus aureus; Methicillin-resistant Staphylococcus epidermidis; Lung infection |
| Core Tip |
Vancomycin and teicoplanin are both essential drugs in the clinical treatment of methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis lung infections and have significant antimicrobial effects on Gram-positive cocci. Here, we discuss the efficacy and safety of these two key antibiotics. |
| Publish Date |
2021-11-30 09:35 |
| Citation |
Wu W, Liu M, Geng JJ, Wang M. Teicoplanin combined with conventional vancomycin therapy for the treatment of pulmonary methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis infections. World J Clin Cases 2021; 9(34): 10549-10556 |
| URL |
https://www.wjgnet.com/2307-8960/full/v9/i34/10549.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v9.i34.10549 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.